ChiCTR-TRC-13004050 版本V1.0 版本创建时间2016/06/19 13:10:52 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR-TRC-13004050 

最近更新日期:

Date of Last Refreshed on:

2015-05-04 10:20:46 

注册时间:

Date of Registration:

2013-08-02 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

CQ01疤贴胶对缓解瘢痕瘙痒作用的临床研究

Public title:

Clinical trial of CQ01 gel to relieve scar itching after burn injury

注册题目简写:

English Acronym:

研究课题的正式科学名称:

CQ01疤贴胶对缓解瘢痕瘙痒作用的临床研究

Scientific title:

Clinical trial of CQ01 gel to relieve scar itching after burn injury

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

罗高兴 

研究负责人:

罗高兴 

Applicant:

Gaoxing LUO 

Study leader:

Gaoxing LUO 

申请注册联系人电话:

Applicant telephone:

+86 023 68754351

研究负责人电话:

Study leader's
telephone:

+86 023 68754351

申请注册联系人传真 :

Applicant Fax:

+86 023 68752688

研究负责人传真:

Study leader's fax:

+86 023 68752688

申请注册联系人电子邮件:

Applicant E-mail:

logxw@yahoo.com

研究负责人电子邮件:

Study leader's E-mail:

logxw@yahoo.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

重庆高滩岩正街30号西南医院烧伤研究所

研究负责人通讯地址:

重庆高滩岩正街30号西南医院烧伤研究所

Applicant address:

30 Gaotanyan Str, Institute of Burn Research, Southwest Hospital, Chongqing, China

Study leader's address:

30 Gaotanyan Str, Institute of Burn Research, Southwest Hospital, Chongqing, China

申请注册联系人邮政编码:

Applicant postcode:

400038

研究负责人邮政编码:

Study leader's postcode:

400038

申请人所在单位:

第三军医大学西南医院烧伤研究所

Applicant's institution:

Institute of Burn Research, Southwest Hospital, Third Military Medical University

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2013-30

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

中国人民解放军第三军医大学第一附属医院伦理委员会

Name of the ethic committee:

Ethics Committee of Southwest Hospital, Third Military Medical University of PLA

伦理委员会批准日期:

Date of approved by ethic committee:

2013-08-05 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

第三军医大学西南医院烧伤研究所

Primary sponsor:

Institute of Burn Research, Southwest Hospital, Third Military Medical University

研究实施负责(组长)单位地址:

重庆高滩岩正街30号西南医院烧伤研究所

Primary sponsor's address:

30 Gaotanyan Street, Shapingba district, Chongqing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆

市(区县):

Country:

China

Province:

Chongqing

City:

单位(医院):

西南医院

具体地址:

重庆高滩岩正街30号

Institution
hospital:

Southwest Hospital Third Military Medical University

Address:

30 Gaotanyan Street, Shapingba district, Chongqing

经费或物资来源:

第三军医大学西南医院

Source(s) of funding:

southwest hospital third military medical university

研究疾病:

瘙痒症  

Target disease:

pruritus

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本课题拟通过临床试验研究,评估CQ01疤贴胶缓解增生性瘢痕引起的瘙痒症的疗效。  

Objectives of Study:

to evaluate the clinical effect of CQ01 gel to relieve scar itching after burn injury.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1)入选病人以自愿为原则,并签署“知情同意书”;
2)烧伤创面愈合后一年内的增生性瘢痕,且伴有中重度瘙痒(瘙痒评分为大于等于40)患者;
3)在身体不同部位有三处以上合并中重度瘙痒的增生性疤痕,且易于分别作为试验区及自身对照区的患者;
4)年龄在16—65周岁,性别不限。

Inclusion criteria

1. patient takes part in the test voluntarily and signs the informed consent statement;
2. one year after burn wound healing of hypertrophic scars, and accompanying with severe itching (pruritus score greater than or equal to 40);
3. The patient has scars on three or more locations, which can be self-paired controlled;
4. age between 16 to 65 years old, no matter of gender;

排除标准:

1) 不同意参加本试验研究的患者;
2) 有皮肤过敏、湿疹、细菌感染、真菌感染等皮肤病患者;
3) 因各种原因不能准确表述瘙痒程度的患者;
4) 有精神或神经病患者;
5) 已怀孕或哺乳期患者;
6) 有明确恶性肿瘤、艾滋病、糖尿病、自身免疫性疾等慢性疾病的患者;
7) 有急慢性肝肾疾病者;
8) 依从性差,难以完成试验者。

Exclusion criteria:

1. patient who does not will to join the test;
2. Have skin allergies, eczema, bacterial or/and fungal infections, and other skin diseases;
3. For various reasons, patient can not represent accurately the degree of pruritus;
4. patient with mental or neurological disease;
5. woman in pregnancy or lactation;
6. Patient with confirmed malignant tumor, AIDS, diabetes,autoimmune and other chonic disease;
7. Patient with chronic hepatic or renal disease;
8. patient can not complete the test for any reasons.

研究实施时间:

Study execute time:

From 2013-08-05 00:00:00 To 2013-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2013-08-05 00:00:00 To 2013-12-31 00:00:00

干预措施:

Interventions:

组别:

对照组

样本量:

72

Group:

control

Sample size:

干预措施:

常规

干预措施代码:

Intervention:

routing

Intervention code:

组别:

条件对照组

样本量:

72

Group:

Condition control

Sample size:

干预措施:

空白胶

干预措施代码:

Intervention:

control gel

Intervention code:

组别:

空白对照组

样本量:

72

Group:

Blank Control

Sample size:

干预措施:

干预措施代码:

Intervention:

NON

Intervention code:

组别:

对照组

样本量:

72

Group:

Control group

Sample size:

干预措施:

基质对照

干预措施代码:

Intervention:

Blank gel control

Intervention code:

组别:

试验组

样本量:

72

Group:

Trial Group

Sample size:

干预措施:

CQ01胶

干预措施代码:

Intervention:

CQ01gel

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆 

市(区县):

重庆 

Country:

China

Province:

Chongqing

City:

单位(医院):

第三军医大学西南医院 

单位级别:

三甲医院 

Institution
hospital:

Southwest Hospital

Level of the institution:

Tertiary A hospital

国家:

中国

省(直辖市):

河南 

市(区县):

郑州 

Country:

China

Province:

Henan

City:

Zhengzhou

单位(医院):

郑州市第一人民医院 

单位级别:

三甲 

Institution
hospital:

The First Hospital of Zhengzhou Henan Province

Level of the institution:

Tertiary A hospital

国家:

中国

省(直辖市):

甘肃 

市(区县):

兰州 

Country:

China

Province:

Gansu

City:

Lanzhou

单位(医院):

兰州军医总医院 

单位级别:

三甲 

Institution
hospital:

Genera Hospital of Lanzhou military district

Level of the institution:

Tertiary A hospital

测量指标:

Outcomes:

指标中文名:

搔痒

指标类型:

主要指标

Outcome:

itchin

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

搔痒改变持续时间

指标类型:

次要指标

Outcome:

persisting time of itching changin

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

血常规肝肾功能检查

Fate of sample:

Destruction after use  

Note:

Check of blood routine and hepatic renal function

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 16 years
最大 Max age 65 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

应用随机数字表与秒表产生随机序列

Randomization Procedure (please state who generates the random number sequence and by what method):

obtain stochastic sequence by random digits table and stop watch

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

数据与安全监察委员会:

Data and Safety Monitoring Committee:

注册人:

Name of Registration:

 2013-12-27 00:00:00